Panama vs United States: Proportion of the target population who received a 3rd dose of
Panama
83.0%
in 2024
United States
84.0%
in 2024
Panama rank
100th
United States rank
98th
Proportion of the target population who received a 3rd dose of over time
- Panama
- United States
How they compare
United States currently reports 84.0% against 83.0% in Panama, a difference of 1.0%.
The two have swapped places 4 times across 15 shared years of data; in 2010 it was United States ahead.
Panama ranks 100th and United States ranks 98th of 157 countries.
United States has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Panama | United States | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 84.2% | 92.6% | 8.4% | United States |
| 2020s | 81.0% | 83.2% | 2.2% | United States |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Panama or United States?
- United States, at 84.0% against 83.0% in Panama as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Panama and United States?
- 1.0%, with United States ahead.
- How many years of comparable data are there for Panama and United States?
- 15 years are reported by both, from 2010 to 2024.
- How do Panama and United States rank globally for proportion of the target population who received a 3rd dose of?
- Panama ranks 100th and United States ranks 98th of 157 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.